15 October 2025 | News
Image Courtesy: Public Domain
Remedy Robotics, Inc. ("Remedy"), a leading medical technology company developing the world's first remotely operated robot for cardiovascular intervention, announced it has entered a strategic partnership with the Australian Stroke Alliance, a consortium representing over 40 government and private sector agencies dedicated to transforming stroke care in Australia. As part of the agreement, the Stroke Alliance has selected Remedy as its exclusive robotics partner to expand access to immediate stroke intervention. Remedy will work with the Stroke Alliance to gain regulatory approval and to roll out its system to hospitals across Australia.
"Partnering with the Australian Stroke Alliance and their world-leading clinical experts is a major step toward delivering rapid endovascular care to stroke and cardiovascular patients in Australia and worldwide," said Dr. David Bell, CEO and Co-Founder of Remedy Robotics. "By combining Remedy's breakthrough technology with the Alliance's vision for stroke care, we're accelerating access to life-saving technology for Australian patients and hospitals. Together, we're redefining what's possible in stroke and cardiovascular care when time to treatment is the single most important factor in determining outcomes."
Cardiovascular diseases, such as stroke, are the number one cause of death and disability worldwide. One in four Australians will experience a stroke in their lifetime, with over 8,000 losing their lives each year and 65% of survivors living with lifelong disability. Endovascular intervention, such as endovascular thrombectomy – a procedure in which clots are removed from the brain – is widely considered the gold standard of treatment for cardiovascular emergencies. However, due to its complexity and the risk of complications, endovascular thrombectomy is only available at select specialist hospitals concentrated in metropolitan areas, significantly limiting access. Because cardiovascular emergencies like stroke are extremely time-sensitive and require immediate intervention, this limited availability is a significant barrier to effective treatment, particularly for Australians living in rural and regional areas.
Professor Stephen Davis AO and Professor Geoffrey Donnan AO, Co-Chairs of the Australian Stroke Alliance, added, "Australia's geography presents a unique challenge in delivering timely stroke care, with many patients living hours from the nearest specialist centre. The vast majority of Australians living outside of major cities cannot access endovascular thrombectomy, which entrenches inequity for rural and Indigenous Australians. Partnering with Remedy Robotics allows us to reimagine what's possible and bring expert stroke intervention to people in rural and remote communities, without delay. This collaboration is a major step toward closing disparities in outcomes between rural and urban Australians while saving lives across the continent."
Improved access to endovascular intervention has the potential to transform cardiovascular care, particularly for stroke, which causes over 160 million disability-adjusted life-years lost every year. In Australia, a study prepared for the Stroke Foundation by Monash University estimated an economic cost of stroke of over $9 billion per year, with over 440,000 survivors living in the community. By 2050 it is estimated that these figures will more than double. These trends are consistent worldwide, making the challenge to increase access to endovascular intervention and thrombectomy all the more urgent.
Remedy Robotics and the Australian Stroke Alliance will together address the critical gap between the time of a stroke and the time of treatment by bringing Remedy's first-of-its-kind technology to Australia and expert stroke care to patients immediately, regardless of their location.
